Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Early magnetic resonance imaging as a predictor of outcome in pediatric traumatic brain injury
Child Neurology and Developmental Neurology
P12 - Poster Session 12 (12:00 PM-1:00 PM)
5-010
The main objective of this retrospective study is to determine the prognostic impact of MRI-defined diffuse axonal injury (DAI) on discharge disposition and functional outcome in pediatric TBI.

Traumatic brain injury (TBI) is the leading cause of disability in children, affecting up to 500,000 children per year. Neuroimaging remains the standard of care in evaluation of TBI although its use in prognostication remains limited. MRI allows for detailed analysis of lesions caused by diffuse axonal injury (DAI), the hallmark pathology described in non-penetrating brain trauma. Imaging studies in pediatric TBI are limited by small sample size, heterogeneous population, varying imaging sequences, and time between injury and imaging.

Patients admitted to Stanford and Santa Clara Valley Medical Center for acute TBI were identified via retrospective chart review. Inclusion criteria were age < 19 years, blunt closed head trauma, MRI obtained during acute hospitalization. The first MRI (GRE or SWI) obtained during the acute hospitalization was used for the analysis of DAI grade. Short term outcome was discharge to acute rehabilitation. Long term outcome was PCPCS at 6-12 months.

108 patients were included. TBI severity was moderately correlated with DAI grade. Higher DAI grade was independently associated with discharge to rehab (p < 0.05) when controlling for GCS and age. Higher DAI grade in severe TBI patients was not associated with poor functional outcome.

DAI grading based on brain MRI was established in adult TBI and is frequently used for prognostication. Our preliminary data suggest that DAI grade can aide in predicting short term outcomes in pediatric patients. Further studies are needed to determine if additional MRI characteristics (non-hemorrhagic lesions on FLAIR and ADC) can be used to enhance prognostication both for short term as well as long term outcomes.

Authors/Disclosures
Anna Janas, MD, PhD (University of Colorado Anschutz Medical Campus)
PRESENTER
Dr. Janas has nothing to disclose.
Zachary D. Threlkeld, MD, FÂé¶¹´«Ã½Ó³»­ (Center for Academic Medicine) Dr. Threlkeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Baim Institute for Clinical Research, Inc.. Dr. Threlkeld has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Medical Legal Consulting. Dr. Threlkeld has received publishing royalties from a publication relating to health care.
Max Wintermark, MD No disclosure on file
Sarah Lee, MD (Stanford Stroke Center) Dr. Lee has nothing to disclose.